How is patency of a Transjugular Intrahepatic Portosystemic Shunt (TIPS) maintained or assessed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TIPS Patency Maintenance and Assessment

TIPS patency is maintained by using PTFE-covered stents and assessed primarily through scheduled Doppler ultrasound surveillance at 6-12 month intervals, with invasive venography reserved only for suspected dysfunction based on clinical symptoms or abnormal ultrasound findings. 1

Maintaining TIPS Patency

Stent Selection

  • All TIPS procedures must use PTFE-covered stents (8-10mm diameter), which achieve >75% patency at 2 years compared to >50% occlusion rates with bare metal stents. 1, 2, 3
  • This represents a strong recommendation with high-level evidence and is the single most important factor for long-term patency. 1

Procedural Targets

  • Reduce the portal pressure gradient to <12 mmHg or achieve ≥20% reduction from baseline during initial placement. 1, 3
  • This threshold minimizes rebleeding risk while balancing hepatic encephalopathy complications. 1

Assessing TIPS Patency

Early Post-Procedure Assessment

  • Early Doppler ultrasound within 7 days is unreliable due to microbubbles obscuring flow in covered stents and should NOT be routinely performed. 1, 2
  • However, confirm TIPS flow before discharge specifically in prothrombotic patients (Budd-Chiari syndrome, portal vein thrombosis). 1, 2
  • Obtain laboratory assessment (transaminases, bilirubin, coagulation studies, CBC) the day after intervention to detect early complications. 2

Routine Surveillance Schedule

  • Perform Doppler ultrasound at 4-6 weeks post-procedure, then every 6-12 months thereafter. 1, 2
  • The 6-month interval conveniently aligns with hepatocellular carcinoma screening schedules. 1, 2, 3
  • This frequency is justified by the 44% dysfunction rate at 2 years even with covered stents. 2

Doppler Ultrasound Parameters to Monitor

Monitor these specific parameters at each examination: 2

  • Maximum flow velocity in the portal vein
  • Flow velocity within the stent tract
  • Flow direction in intrahepatic portal vein branches
  • Flow velocity in upstream portal vein and downstream hepatic vein

Concerning findings suggesting stenosis include: 2

  • Increased or decreased flow velocities within the shunt
  • Decreased flow velocity in the portal vein trunk
  • Reversal of flow direction in portal vein branches
  • Peak shunt velocity <90 cm/s 4

When to Proceed to Invasive Venography

Perform TIPS venography and manometry only when: 1, 2

  • Doppler ultrasound shows findings suspicious for dysfunction
  • Clinical signs of recurrent portal hypertension appear (ascites, variceal rebleeding)
  • Patient has prothrombotic conditions requiring more intensive surveillance

Critical caveat: Doppler ultrasound has only 33-95% specificity with 50% false positive rates for detecting TIPS dysfunction. 1, 2 Therefore, clinical context determines whether to act on abnormal ultrasound findings. 1

Clinical Decision Algorithm for Intervention

For patients with TIPS placed for varices: 1

  • Any clinical or ultrasound findings suggesting stenosis → proceed to venography and manometry
  • Stenosis increases portosystemic gradient and rebleeding risk, requiring prompt intervention

For patients with TIPS placed for ascites/hepatic hydrothorax: 1

  • If ascites remains well-controlled despite ultrasound findings → venography may not be necessary
  • If ascites recurs → proceed to venography regardless of ultrasound findings

For patients with portal vein thrombosis: 1, 2

  • Perform routine scheduled venography within 1-2 months after recanalization
  • Assess for residual thrombus, perform additional recanalization if needed
  • Embolize competing portosystemic shunts to maintain portal vein patency

Alternative Cross-Sectional Imaging

  • Contrast-enhanced portal-venous CT angiography is the optimal method for anatomical visualization of the portal venous system. 2
  • Perform CT angiography at 6-12 months to assess portal venous recanalization. 2
  • MR angiography is less optimal due to metal artifacts making stenosis quantification difficult. 2

Special Populations Requiring Intensive Surveillance

Prothrombotic conditions (Budd-Chiari syndrome, portal vein thrombosis): 1, 2, 5

  • More frequent Doppler ultrasound surveillance beyond standard intervals
  • Lower threshold for proceeding to venography
  • Consider routine scheduled venography as determined by interventional radiology

Patients with prior TIPS dysfunction and successful revision: 5

  • Significantly higher risk of recurrent dysfunction (p=0.001)
  • Continue detailed long-term surveillance beyond 2 years

When Surveillance Can Be Reduced

After 2 years of unremarkable follow-up in asymptomatic patients without prothrombotic states, detailed surveillance has minimal therapeutic impact (0.75%) and can be reduced. 5

No TIPS dysfunction occurs more than 4 years after implantation in most patients. 5

Common Pitfalls to Avoid

  • Do NOT perform routine invasive venography in the absence of clinical or ultrasound suspicion of dysfunction. 1, 2 This represents unnecessary risk and cost.
  • Do NOT rely on early (<7 days) Doppler ultrasound for covered stents as microbubbles obscure interpretation. 1, 2
  • Do NOT ignore clinical symptoms even with normal ultrasound, as ultrasound has high false negative rates. 1, 5
  • Do NOT continue intensive surveillance indefinitely in low-risk patients with normal function at 2 years. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Portal Vein Thrombosis with Stent Follow-Up Imaging Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Portal Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.